Drugs / BPT567
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06779851 | Oct 2024 → Jan 2026 | cancer | Bright Peak Therapeutics Inc | Terminated | No outcome recorded Stop: Business |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2024-04-09 | Bright Peak Therapeutics Inc | Results Bright Peak Therapeutics Presents New Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting brightpeaktx.com ↗ |
| 2023-04-17 | Bright Peak Therapeutics Inc | Results Bright Peak Presents New Data at AACR: BPT567 A First-in-Class Multifunctional αPD1-IL18 Immunocytokine brightpeaktx.com ↗
Accordingly, after BPT567 administration, marked expansion of CD8+ effector memory cells was observed within the tumor with minimal expansion in the blood, while the proportion of regulatory T cells (Tregs) was significantly suppressed in the tumor and unchanged in the blood. |
All press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-10-17 | Bright Peak Therapeutics Inc | Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567, a First-in-Class Bifunctional PD1-IL18 Immunoconjugate brightpeaktx.com ↗ |
| 2024-04-09 | Bright Peak Therapeutics Inc | Bright Peak Therapeutics Presents New Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting brightpeaktx.com ↗ |
| 2023-04-17 | Bright Peak Therapeutics Inc | Bright Peak Presents New Data at AACR: BPT567 A First-in-Class Multifunctional αPD1-IL18 Immunocytokine brightpeaktx.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BPT567 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06779851 ↗ |
| Modality | Protein / enzyme biologic | “BPT567, a Multifunctional PD1-IL18 Immunocytokine” NCT06779851 ↗ |
| Route | Other | “Immunocytokine infusion” NCT06779851 ↗ |